News
But MASH goes far beyond Hollywood, as these mobile medical teams played a critical role on the front lines, providing care ...
17h
InvestorsHub on MSNMadrigal Pharmaceuticals shares surge after extended patent protection for MASH therapyMadrigal Pharmaceuticals Inc. (NASDAQ:MDGL) saw its stock climb 6.1% following the announcement that the U.S. Patent and Trademark Office has issued a Notice of Allowance for its MASH treatment, ...
The extended patent protection strengthens Madrigal’s market position by preventing generic competition for over two decades, potentially securing long-term revenue streams for the biopharmaceutical ...
Multi-agency safeguarding hub (MASH) practitioners are unsure over when and how to seek parental consent to share information ...
Mash Bash blood drive, hosted by Our Blood Institute, will be held from 8 a.m. to 6 p.m. Friday at Uptown Hot Springs, ...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
Explore more
By Daniella Parra Inventiva said Dr. Jason Campagna has been named President of R&D and Chief Medical Officer as Inventiva ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results